Curexa

Form 483 issued October 9, 2020 · Egg Harbor Township, New Jersey

Inspection
Aug 26 – Oct 9, 2020
Observations
3
Pages
4
FEI number
3011761882

In short: On October 9, 2020, FDA issued a Form 483 with 3 observations to Curexa in Egg Harbor Township, New Jersey (FEI 3011761882) after an inspection that ran Aug 26 – Oct 9, 2020. The investigators were Nancy M. Espinal and William J. Muszynski. Most observations concern quality system and facilities & equipment; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

Quality system and facilities & equipment account for 2 of 3 observations.

Quality system1
Facilities & equipment1
Other1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01
    FDCA 501(a)(2)(A)

    Non-microbial contamination was observed…

  2. 02

    Laboratory analysis of hormone sample determined the strength was below…

  3. 03

    Buildings used in the processing of a chug product are not maintained in a…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Curexa?

FDA listed 3 observations on this Form 483, mostly about quality system and facilities & equipment. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected Curexa?

Nancy M. Espinal and William J. Muszynski are named on this Form 483, for the inspection of Aug 26 – Oct 9, 2020. Each investigator has a profile showing what they cite most.

When was Curexa inspected by FDA?

The inspection ran Aug 26 – Oct 9, 2020, and the Form 483 is dated October 9, 2020.

How do I get the full Form 483 for Curexa?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free